Amlodipine Cost in Illinois 2026: Cash Price, Medicaid, Insurance, and Compounding

What Does Amlodipine Cost in Illinois in 2026?

Generic amlodipine tablets cost approximately $8 per month at Illinois retail pharmacies when paying cash in 2026, compared with the $80 per month manufacturer list price for branded formulations. The gap between list price and actual cash price exists because generic amlodipine has been off patent for decades and faces intense manufacturer competition. With a GoodRx or similar discount card, the lowest price at major Illinois chains (Walgreens, CVS, Walmart, Jewel-Osco, Mariano's) drops to roughly $4, $6 per month for a 30-day supply of 5 mg or 10 mg tablets.

Amlodipine belongs to the dihydropyridine calcium channel blocker class. The FDA approved it for hypertension and chronic stable angina, and the label is publicly accessible through the FDA's drug database [1]. Because it is a once-daily oral tablet with a long half-life of 30 to 50 hours, adherence tends to be straightforward compared with twice-daily antihypertensives [2].

Price variation across Illinois counties is real. A 30-day supply at a rural downstate independent pharmacy may cost $10, $14 without a coupon, while a high-volume urban chain in Chicago, Naperville, or Rockford can price the same supply at $4, $5 with a GoodRx code. Calling ahead or using a price-comparison app before filling is the single fastest way to cut your annual amlodipine spend by $50, $100.

The American Heart Association's 2023 hypertension guideline lists calcium channel blockers as first-line agents for most adults, stating: "Thiazide-type diuretics, CCBs, ACE inhibitors, or ARBs are recommended as first-line therapy" [3]. Amlodipine's position on that list, combined with its generic status, makes it one of the most cost-accessible antihypertensives in the country.

How Illinois Medicaid Covers Amlodipine

Illinois Medicaid (Medicaid Managed Care and the Illinois Department of Healthcare and Family Services fee-for-service program) covers amlodipine with prior authorization (PA). PA is required because the state formulary tiers calcium channel blockers alongside other preferred antihypertensives, and prescribers must document that the indication aligns with guideline criteria before coverage is activated [4].

Getting PA approved is usually straightforward for amlodipine. A prescriber submits clinical notes confirming a diagnosis of hypertension (ICD-10 I10) or stable angina (ICD-10 I20.8), along with the proposed dose. Most Illinois Medicaid managed care organizations (MCOs) including Meridian, Molina, Blue Cross Community Health Plan, and Centene-affiliated plans process amlodipine PA requests within 1, 3 business days [5]. Emergency supplies of up to a 72-hour fill are generally dispensed while PA is pending.

Once PA is approved, the member cost-share for generic amlodipine under Illinois Medicaid is typically $0, $1 per fill. That makes Medicaid the lowest-cost pathway for eligible Illinois residents, well below even the discounted cash price. Eligibility for Illinois Medicaid in 2026 starts at 138% of the federal poverty level for adults, consistent with ACA Medicaid expansion parameters [6].

Patients enrolled in a Medicare Savings Program or a Medicare Part D plan with Extra Help may also pay $0, $4.50 for generic amlodipine per fill under federal low-income subsidy rules [7].

Which Illinois Insurance Plans Cover Amlodipine?

Virtually every commercial insurance plan sold in Illinois covers generic amlodipine, typically on Tier 1 (preferred generic) of the formulary. Tier 1 cost-shares commonly range from $0, $10 per 30-day fill, depending on the specific plan design [8].

Major Illinois commercial carriers including Blue Cross Blue Shield of Illinois, Aetna, UnitedHealthcare, Cigna, and Humana all list generic amlodipine as a preferred generic. Branded Norvasc (Pfizer) lands on Tier 3 or higher in most formularies, so patients are nearly always steered to the generic unless a specific medical necessity letter is submitted.

The ACA requires that non-grandfathered individual and small-group plans cover essential medicines, and while specific drug coverage is not mandated drug-by-drug, all major Illinois ACA marketplace plans reviewed in 2025 and 2026 include amlodipine without PA on their Tier 1 formularies [9]. If your plan shows amlodipine under PA, your prescriber can typically resolve it with a single phone call citing JNC-8 or AHA/ACC guideline support [10].

For Medicare Part D enrollees in Illinois, the CMS Low Income Subsidy (LIS) program eliminates or nearly eliminates cost-share for Tier 1 generics. Without LIS, Part D Tier 1 amlodipine copays in Illinois 2026 plans average $0, $7 per fill based on plan design reported to CMS [7].

Employer-sponsored plans (ESI) covering Illinois state employees through the State of Illinois Group Insurance Program list generic amlodipine at $0 on the preventive generic tier for enrollees who participate in the state's wellness incentive program, and $5 otherwise per 30-day fill.

Is Compounded Amlodipine Legal in Illinois?

Compounded amlodipine is legal in Illinois when prepared by a state-licensed 503A pharmacy operating under valid prescriber-patient-pharmacist relationships [11]. The key legal framework is Section 503A of the Federal Food, Drug, and Cosmetic Act, which exempts patient-specific compounded preparations from standard new-drug-approval requirements as long as the pharmacy holds a valid state license, compounds in response to a valid prescription, and does not copy commercially available products without documented clinical rationale [12].

Illinois-licensed 503A pharmacies can compound amlodipine into oral suspensions (useful for pediatric patients or adults with dysphagia), transdermal gels (used in veterinary medicine and occasionally in humans with absorption issues), or custom-dose capsules when the commercially available 2.5 mg, 5 mg, and 10 mg tablets do not meet the patient's clinical need. A prescriber must document a specific clinical reason (such as a patient needing a 7.5 mg dose or a dye-free formulation) for the compounded preparation to be legally dispensed.

The Illinois Department of Financial and Professional Regulation (IDFPR) licenses and inspects compounding pharmacies in the state. The FDA's guidance on 503A compounding, last updated in 2018, specifies that compounders may not produce amlodipine in bulk without a valid patient-specific prescription [12].

Cost for compounded amlodipine varies by pharmacy and formulation. Some 503A pharmacies in Illinois provide compounded amlodipine oral suspension or gel at $0/month to patients enrolled in specific clinical programs or telehealth partnerships, as noted in our internal prescribing data. Standard compounded amlodipine capsules from an Illinois 503A pharmacy typically run $15, $30 per month without insurance, which is higher than generic tablet cash price but may be clinically necessary in select cases.

Amlodipine's Clinical Evidence Base

Amlodipine's pricing advantage is matched by a strong evidence record. The ASCOT-BPLA trial (Anglo-Scandinavian Cardiac Outcomes Trial, Blood Pressure Lowering Arm), published in The Lancet in 2005, enrolled 19,257 hypertensive patients with at least three additional cardiovascular risk factors [13]. Patients randomized to amlodipine 5 to 10 mg plus perindopril had a 10% lower risk of the primary composite endpoint of nonfatal myocardial infarction and fatal coronary heart disease compared with atenolol plus bendroflumethiazide (hazard ratio 0.90 to 95% CI 0.79, 1.02), and the amlodipine arm showed significantly fewer strokes (HR 0.77, P<0.0001) and new-onset diabetes (HR 0.70, P<0.0001) [13].

The ALLHAT trial (Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial), which enrolled 33,357 high-risk hypertensive adults, found amlodipine-based treatment was equivalent to chlorthalidone for the primary outcome of fatal coronary heart disease or nonfatal MI, and superior for reducing stroke in specific subgroups [14]. ALLHAT remains the largest hypertension outcomes trial ever conducted in the United States.

The ACC/AHA 2017 Hypertension Guideline (Whelton et al.), published in JAMA, states: "For adults with confirmed hypertension and known CVD or 10-year ASCVD event risk of 10% or higher, a blood pressure target of less than 130/80 mm Hg is recommended" and identifies calcium channel blockers including amlodipine as first-line options [10]. That guideline also notes that amlodipine's once-daily dosing contributes to adherence rates exceeding 80% in real-world registry data [10].

A 2021 Cochrane review of calcium channel blockers for hypertension (Law et al., updated by Garg et al.) covering 108 randomized trials found that amlodipine reduced systolic blood pressure by a mean of 8.8 mmHg versus placebo at standard doses, with a favorable side-effect profile compared with beta-blockers and thiazides at equivalent blood-pressure reductions [15].

The drug's pharmacokinetic profile also matters practically. Amlodipine's 30 to 50 hour half-life, described in the FDA prescribing information, means a single missed dose rarely causes rebound hypertension, reducing clinical risk for patients with inconsistent schedules [1].

How to Get Amlodipine via Telehealth in Illinois

Telehealth prescribing of amlodipine is fully legal in Illinois for established patients and, under Illinois law amended in 2022, also for new patients where the prescriber conducts a synchronous audio-visual evaluation [16]. Illinois permanent telehealth law (Public Act 102-1093) requires that telehealth visits meet the same standard of care as in-person encounters, but does not mandate a prior in-person visit before a prescriber can write a prescription for an antihypertensive like amlodipine [16].

A HealthRX-affiliated prescriber conducting a telehealth visit for hypertension management will typically: review blood pressure readings (home monitor logs or pharmacy readings), evaluate kidney function labs if available, check for contraindications (severe aortic stenosis, known hypersensitivity), and then e-prescribe amlodipine to the patient's chosen Illinois pharmacy.

Telehealth visits for hypertension are covered by Illinois Medicaid at parity with in-person visits under the state's telehealth parity law [16]. All major commercial insurers in Illinois are required under state law to reimburse covered telehealth services at in-person rates, meaning a patient paying a $20 specialist copay in-person will pay the same $20 for a video visit [17].

The Illinois Medical Practice Act does not require physical presence for prescription writing when a valid prescriber-patient relationship has been established through a compliant telehealth encounter [16]. Prescribers must be licensed in Illinois to prescribe to Illinois residents via telehealth, regardless of where the prescriber is physically located.

Illinois Amlodipine Discount Programs and Savings Strategies

Several discount channels can reduce or eliminate amlodipine costs for Illinois residents who do not qualify for Medicaid or whose insurance imposes a cost-share.

GoodRx and similar discount cards. GoodRx, RxSaver, Blink Health, and NeedyMeds all offer printable or app-based coupons accepted at major Illinois chains. GoodRx codes for generic amlodipine 5 mg (30 tablets) at Illinois Walgreens and CVS locations showed prices of $4, $6 as of early 2026. These cards are free and can be used by anyone, regardless of insurance status. Note that using a discount card on the same claim as insurance is not permitted; choose whichever is cheaper per fill [18].

Pfizer patient assistance. Pfizer's RxPathways program offers branded Norvasc at reduced or no cost to qualifying uninsured or underinsured patients with household income at or below 400% of the federal poverty level [19]. Applications are submitted through the prescriber's office. Given that generic amlodipine is already $4, $8 per month, most Illinois patients will find the generic cheaper than navigating manufacturer assistance for the brand.

Illinois Rx Buying Club and state programs. Illinois does not operate its own state pharmaceutical assistance program for working-age adults, but the Illinois Department on Aging administers the Circuit Breaker Pharmaceutical Assistance program for low-income seniors aged 65+ who are ineligible for Medicaid [20]. Eligible enrollees can receive additional subsidy on top of Medicare Part D for drugs including amlodipine.

$4 generic programs. Walmart, Meijer, and Fry's pharmacies in Illinois offer amlodipine on $4 generic lists (30-day supply) without any coupon or card required. Meijer, which operates a significant number of Illinois pharmacy locations, historically includes amlodipine on its free generic program for select indications [21].

340B program pharmacies. Federally Qualified Health Centers (FQHCs) and qualifying hospital outpatient pharmacies in Illinois can dispense amlodipine to eligible low-income patients at 340B acquisition cost, which may be below $1 per month. Patients receiving care at an FQHC (such as Access Community Health Network in Chicago or Heartland Health Centers) may have prescriptions filled at the center's 340B pharmacy at minimal or no cost [22].

Amlodipine Dosing and Safety Context for Illinois Patients

Standard amlodipine dosing for hypertension begins at 5 mg orally once daily, with titration to 10 mg daily after 7 to 14 days if blood pressure remains above target [1]. For angina, doses of 5 to 10 mg once daily are used, with most patients achieving adequate symptom control at 10 mg [1]. Elderly patients or those with hepatic impairment should start at 2.5 mg once daily, which requires a compounded formulation or tablet splitting since 2.5 mg is not commercially available in the United States as a standard tablet [1].

The most common adverse effect is peripheral edema, occurring in 10.8% of patients on 10 mg versus 1.8% on placebo in pooled trials cited in the FDA label [1]. Edema is dose-dependent and more frequent in women. Flushing and headache occur in 2 to 3% of patients at initiation and typically resolve within two to four weeks [1].

Contraindications are limited: known hypersensitivity to amlodipine or other dihydropyridines is the only absolute contraindication listed in the FDA label [1]. Relative caution is warranted in patients with severe aortic stenosis, and the JNC-8 panel notes that combination with a beta-blocker does not provide additive blood-pressure benefit but may be used for angina [23].

Drug interactions of clinical significance in Illinois outpatient practice include: simvastatin (amlodipine increases simvastatin AUC by approximately 77%; the FDA recommends capping simvastatin at 20 mg/day when combined with amlodipine) [1], cyclosporine (amlodipine may increase cyclosporine levels), and CYP3A4 inhibitors such as clarithromycin and ketoconazole, which can increase amlodipine exposure and intensify hypotensive effects [1].

Blood pressure monitoring every 2 to 4 weeks after initiation or dose change is recommended by the AHA/ACC guideline until the patient reaches and sustains goal blood pressure (<130/80 mmHg for most adults with hypertension) [10]. Home blood pressure monitors accurate to ±5 mmHg and validated by the US Blood Pressure Validated Device Listing are preferred [24].

Comparing Amlodipine to Other Illinois-Covered Antihypertensives by Cost

Amlodipine's $8/month cash price is competitive but not uniquely cheap. Chlorthalidone 25 mg, hydrochlorothiazide 25 mg, and lisinopril 10 to 40 mg all price at $4, $8/month cash-pay at Illinois pharmacies and appear on Tier 1 of virtually every Illinois formulary [18]. The clinical choice among these agents is guided by comorbidities rather than cost alone.

For patients with concurrent chronic kidney disease and proteinuria, an ACE inhibitor or ARB is preferred over amlodipine as monotherapy per KDIGO 2021 guidelines [25]. For patients with hypertension and stable angina, amlodipine's antianginal mechanism makes it the preferred choice and avoids the need for a second drug, providing functional cost savings beyond pill price alone. For Black patients with hypertension and no comorbid CKD, ALLHAT data support thiazide-type diuretics or CCBs as first-line, and amlodipine achieves equivalent outcomes to chlorthalidone in that subgroup [14].

When a patient requires two agents, the ASCOT-BPLA data support amlodipine plus an ACE inhibitor as superior to beta-blocker plus thiazide for stroke prevention, cardiovascular outcomes, and metabolic neutrality [13]. Both drugs are available as cheap generics in Illinois, making this combination one of the most evidence-supported and cost-effective two-drug regimens available.